BioAge Labs, Inc. (BIOA)
6.36
-0.25
(-3.78%)
USD |
NASDAQ |
Oct 05, 16:00
6.35
-0.01
(-0.16%)
After-Hours: 20:00
BioAge Labs Market Cap : 291.14M for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 291.14M |
| October 02, 2026 | 302.59M |
| October 01, 2026 | 311.74M |
| September 30, 2026 | 324.56M |
| September 29, 2026 | 326.85M |
| September 28, 2026 | 328.68M |
| September 25, 2026 | 322.73M |
| September 24, 2026 | 330.05M |
| September 23, 2026 | 361.18M |
| September 22, 2026 | 387.27M |
| September 21, 2026 | 370.34M |
| September 18, 2026 | 368.96M |
| September 17, 2026 | 370.34M |
| September 16, 2026 | 354.77M |
| September 15, 2026 | 374.46M |
| September 14, 2026 | 388.19M |
| September 11, 2026 | 388.65M |
| September 10, 2026 | 395.97M |
| September 09, 2026 | 419.77M |
| September 08, 2026 | 430.07M |
| September 04, 2026 | 439.00M |
| September 03, 2026 | 434.88M |
| September 02, 2026 | 445.41M |
| September 01, 2026 | 435.80M |
| August 31, 2026 | 434.88M |
| Date | Value |
|---|---|
| August 28, 2026 | 441.75M |
| August 27, 2026 | 461.43M |
| August 26, 2026 | 450.44M |
| August 25, 2026 | 462.80M |
| August 24, 2026 | 429.39M |
| August 21, 2026 | 433.96M |
| August 20, 2026 | 443.58M |
| August 19, 2026 | 492.10M |
| August 18, 2026 | 478.83M |
| August 17, 2026 | 476.08M |
| August 14, 2026 | 485.24M |
| August 13, 2026 | 477.45M |
| August 12, 2026 | 479.74M |
| August 11, 2026 | 488.44M |
| August 10, 2026 | 524.15M |
| August 07, 2026 | 536.51M |
| August 06, 2026 | 515.91M |
| August 05, 2026 | 502.63M |
| August 04, 2026 | 512.70M |
| August 03, 2026 | 493.48M |
| July 31, 2026 | 401.26M |
| July 30, 2026 | 1.103B |
| July 29, 2026 | 984.94M |
| July 28, 2026 | 972.96M |
| July 27, 2026 | 926.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neumora Therapeutics, Inc. | 98.15M |
| Alumis, Inc. | 878.98M |
| ANI Pharmaceuticals, Inc. | 1.667B |
| Corcept Therapeutics, Inc. | 13.17B |
| Veru, Inc. | 43.48M |
Market Cap Related Metrics
| PS Ratio | 24.46 |
| PEG Ratio | -0.3948 |
| Price to Book Value | 0.7766 |
| Price | 6.36 |
| Earnings Yield | -37.53% |
| PEGY Ratio | -0.3948 |